Gori, Alessia
 Distribuzione geografica
Continente #
AS - Asia 25
NA - Nord America 23
EU - Europa 16
AF - Africa 1
Totale 65
Nazione #
SG - Singapore 24
US - Stati Uniti d'America 23
IT - Italia 7
DE - Germania 4
CZ - Repubblica Ceca 2
FI - Finlandia 2
CN - Cina 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 65
Città #
Singapore 21
Santa Clara 7
Rome 5
Munich 4
Brno 2
Helsinki 2
Ashburn 1
Johannesburg 1
Los Angeles 1
Moscow 1
Totale 45
Nome #
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 13
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 12
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 11
Amino acid variability of small molecule inhibitors and mAbs target sites in globally circulating RSV strains 11
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 9
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 9
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 8
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 7
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 6
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 6
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 6
Totale 98
Categoria #
all - tutte 653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202449 0 0 0 0 0 0 0 0 4 42 0 3
2024/202549 11 38 0 0 0 0 0 0 0 0 0 0
Totale 98